Emerging roles of β-cell mitochondria in type-2-diabetes

被引:0
|
作者
Las, Guy [1 ]
Oliveira, Marcus F. [2 ]
Shirihai, Orian S. [3 ]
机构
[1] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem & Pharmacol, Beer Sheva, Israel
[2] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, Cidade Univ, Rio De Janeiro, RJ, Brazil
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Endocrinol, Los Angeles, CA 90095 USA
关键词
Mitochondria; Type-2-diabetes; beta-Cell; Free fatty acids; FREE FATTY-ACIDS; INDUCED INSULIN-SECRETION; OXYGEN SPECIES PRODUCTION; HUMAN PANCREATIC-ISLETS; ENZYME GENE-EXPRESSION; OXIDATIVE STRESS; DIABETES-MELLITUS; SUPEROXIDE-PRODUCTION; AUTOPHAGIC TURNOVER; GLUCOSE-TOLERANCE;
D O I
10.1016/j.mam.100843
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Type-2-Diabetes (T2D) is the most common metabolic disease in the world today. It erupts as a result of peripheral insulin resistance combined with hyperinsulinemia followed by suppression of insulin secretion from pancreatic beta-cells. Mitochondria play a central role in beta-cells by sensing glucose and also by mediating the suppression of insulin secretion in T2D. Here, we will summarize the evidence accumulated for the roles of beta-cells mitochondria in T2D. We will present an updated view on how mitochondria in beta-cells have been associated with T2D, from the genetic, bioenergetic, redox and structural points of view. The emerging picture is that mitochondrial structure and dysfunction directly contribute to beta-cell function and in the pathogenesis of T2D.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Neurohumoral stimulation in type-2-diabetes as an emerging disease concept
    Pliquett, R. U.
    Fasshauer, M.
    Blueher, M.
    Paschke, R.
    CARDIOVASCULAR DIABETOLOGY, 2004, 3 (1)
  • [2] Neurohumoral stimulation in type-2-diabetes as an emerging disease concept
    RU Pliquett
    M Fasshauer
    M Blüher
    R Paschke
    Cardiovascular Diabetology, 3
  • [3] Gene Type-2-Diabetes A Portal helps to understand Type-2-Diabetes better
    不详
    DIABETES STOFFWECHSEL UND HERZ, 2016, 25 (04): : 258 - 258
  • [4] Prevention of the Type-2-Diabetes
    Stefan, N.
    Fritsche, A.
    Haering, H. -U.
    DIABETOLOGIE UND STOFFWECHSEL, 2008, 3 (04) : R57 - R68
  • [5] Therapy of Type-2-Diabetes
    Landgraf, Ruediger
    Aberle, Jens
    Birkenfeld, Andreas L.
    Gallwitz, Baptist
    Kellerer, Monika
    Klein, Harald
    Mueller-Wieland, Dirk
    Nauck, Michael A.
    Reuter, Hans-Martin
    Siegel, Erhard
    DIABETOLOGE, 2021, 17 (04): : 422 - 447
  • [6] Therapy of Type-2-Diabetes
    Landgraf, Ruediger
    Kellerer, Monika
    Fach, Eva-Maria
    Gallwitz, Baptist
    Hamann, Andreas
    Joost, Hans-Georg
    Klein, Harald
    Mueller-Wieland, Dirk
    Nauck, Michael A.
    Reuter, Hans-Martin
    Schreiber, Stephan
    Siegel, Erhard
    DIABETOLOGIE UND STOFFWECHSEL, 2017, 12 : S141 - S156
  • [7] Type-2-Diabetes in Adolescence
    Pavlicek, V.
    DIABETOLOGE, 2012, 8 (05): : 412 - 413
  • [8] Amyloid Formation in Type-2-Diabetes
    不详
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (08) : 442 - 442
  • [9] Emerging roles of selenium on metabolism and type 2 diabetes
    Zhao, Jiuxiang
    Zou, Hong
    Huo, Yanling
    Wei, Xiaoyi
    Li, Yu
    FRONTIERS IN NUTRITION, 2022, 9
  • [10] Early detection of Type-2-Diabetes
    不详
    DIABETES STOFFWECHSEL UND HERZ, 2019, 28 (03): : 156 - 156